Press Release Details
Colfax Reports Preliminary Third Quarter Results
The preliminary results for the three and nine months ended
On a year-over-year basis, highlights for the quarter and the first nine months of 2010 include:
Third quarter of 2010 (all comparisons versus the third quarter of 2009)
- Net income of
$5.8 million (13 cents per share -- basic and diluted); adjusted net income (as defined below) of$9.5 million (22 cents per share), a decrease of 6.2% including currency effects and one-time acquisition costs of3 cents per share - Net sales of
$132.4 million , an increase of 3.0%; organic sales increase (as defined below) of 5.9% - Operating income of
$8.6 million ; adjusted operating income (as defined below) of$15.6 million , a decrease of 7.3%. Excluding currency effects and one-time acquisition costs totaling$1.7 million , adjusted operating income increased$0.5 million or 2.8%. - Third quarter orders of
$124.1 million , an increase of 5.9%; organic order growth (as defined below) of 8.1% - Backlog of
$351.2 million at period end
Year-to-date 2010 (all comparisons versus the first nine months of 2009)
- Net income of
$7.6 million (17 cents per share -- basic and diluted); adjusted net income (as defined below) of$23.3 million (53 cents per share), a decrease of 20.9% including currency effects and one-time acquisition costs of2 cents per share - Net sales of
$375.3 million , a decrease of 4.7%; organic sales decline (as defined below) of 5.0% - Operating income of
$14.8 million ; adjusted operating income (as defined below) of$39.3 million , a decrease of 19.4%. Excluding currency effects and one-time acquisition costs totaling$1.2 million , adjusted operating income decreased$8.3 million or 17.0%. - Orders for the nine month period of
$399.2 million , an increase of 10.7%; organic order growth (as defined below) of 10.1%
Adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth (decline) and organic order growth (decline) are not financial measures calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP"). See below for a description of the measures' usefulness and a reconciliation of these measures to their most directly comparable preliminary GAAP financial measures.
"We're pleased to report stronger than expected results for the third quarter," said
He added, "We're continuing to gain traction with our strategic improvement priorities, including
Non-GAAP Financial Measures and Other Adjustments
Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth (decline), organic order growth (decline) and projected adjusted net income per share. Adjusted net income, adjusted net income per share and adjusted operating income exclude asbestos liability and defense costs (income) and asbestos coverage litigation expenses, and restructuring and other related charges to the extent they impact the periods presented. Adjusted net income, adjusted net income per share and projected adjusted net income per share present income taxes at an effective tax rate of 32%. Projected adjusted net income per share excludes actual and estimated restructuring and other related charges, asbestos coverage litigation expenses and asbestos liability and defense costs. Organic sales growth (decline) and organic order growth (decline) exclude the impact of acquisitions and foreign exchange rate fluctuations. These non-GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of non-recurring items, legacy asbestos issues and items outside the control of its operating management team.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.
Conference Call and Webcast
Colfax will host a conference call to provide details about its preliminary results and outlook on
About
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to factors detailed in Colfax's reports filed with the
The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by
Colfax Corporation | |||||||||
Condensed Consolidated Statements of Operations | |||||||||
Dollars in thousands, except per share data | |||||||||
(Preliminary(1) and unaudited) | |||||||||
Three Months Ended | Nine Months Ended | ||||||||
October 1, 2010 | October 2, 2009 | October 1, 2010 | October 2, 2009 | ||||||
As Restated | As Restated | ||||||||
Net sales | $ 132,397 | $ 128,545 | $ 375,336 | $ 394,053 | |||||
Cost of sales | 85,300 | 82,339 | 243,502 | 255,277 | |||||
Gross profit | 47,097 | 46,206 | 131,834 | 138,776 | |||||
Selling, general and administrative expenses | 29,930 | 27,876 | 87,836 | 85,468 | |||||
Research and development expenses | 1,583 | 1,523 | 4,731 | 4,610 | |||||
Restructuring and other related charges | 2,441 | 9,608 | 9,515 | 10,755 | |||||
Asbestos liability and defense costs (income) | 2,202 | (4,303) | 4,179 | (1,176) | |||||
Asbestos coverage litigation expenses | 2,339 | 1,845 | 10,763 | 8,838 | |||||
Operating income | 8,602 | 9,657 | 14,810 | 30,281 | |||||
Interest expense | 1,544 | 1,834 | 5,075 | 5,466 | |||||
Income before income taxes | 7,058 | 7,823 | 9,735 | 24,815 | |||||
Provision for income taxes | 1,222 | 2,294 | 2,176 | 7,750 | |||||
Net income | $ 5,836 | $ 5,529 | $ 7,559 | $ 17,065 | |||||
Net income per share -- basic and diluted | $ 0.13 | $ 0.13 | $ 0.17 | $ 0.39 | |||||
(1) The preliminary results for the three and nine months ended October 1, 2010 and the preliminary restated results for the three and nine months ended October 2, 2009, included herein, reflect management's best estimate of corrections related to the overstatement of the Company's pension liability as described in the Form 8-K filed with the SEC on October 25, 2010. Selling, general and administrative expenses for the nine months ended October 1, 2010, include an estimated correction related to the first six months of 2010, resulting in a reduction of $0.5 million compared to the historical results reported in the Company's Quarterly Report on Form 10-Q for the period ended July 2, 2010. The related net income impact for nine months ended October 1, 2010 is an after-tax benefit of $0.3 million ($.01 per share). Selling, general and administrative expenses for the three and nine months ended October 2, 2009, include estimated corrections resulting in reductions of $0.3 million and $0.8 million, respectively, compared to the historical results reported in the Company's Quarterly Report on Form 10-Q for the period ended October 2, 2009. The related net income impacts for the three and nine months ended October 2, 2009, are after-tax benefits of $0.2 million (less than $.01 per share) and $0.5 million ($.01 per share), respectively. Final results for the current year periods and final restated results for the 2009 periods could change when the analysis of the pension matter is finalized, and these final results will be reflected in the Company's Quarterly Report on Form 10-Q for the period ended October 1, 2010 and amended prior reports, when filed. The Company will amend and restate the consolidated financial statements contained it its Annual Report on Form 10-K for the year ended December 31, 2009 and Quarterly Reports on Form 10-Q for the periods ended April 2, 2010 and July 2, 2010. The Company plans to file the amended reports as soon as practicable in the fourth quarter of 2010. | |||||||||
Colfax Corporation | |||||||||
Reconciliation of GAAP to non-GAAP Financial Measures | |||||||||
Dollars in thousands, except per share data | |||||||||
(Preliminary(1) and unaudited) | |||||||||
Three Months Ended | Nine Months Ended | ||||||||
October 1, 2010 | October 2, 2009 | October 1, 2010 | October 2, 2009 | ||||||
As Restated | As Restated | ||||||||
Adjusted Net Income and Adjusted Earnings per Share | |||||||||
Net income | $ 5,836 | $ 5,529 | $ 7,559 | $ 17,065 | |||||
Restructuring and other related charges | 2,441 | 9,608 | 9,515 | 10,755 | |||||
Asbestos liability and defense costs (income) | 2,202 | (4,303) | 4,179 | (1,176) | |||||
Asbestos coverage litigation expenses | 2,339 | 1,845 | 10,763 | 8,838 | |||||
Tax adjustment to effective rate of 32% | (3,271) | (2,497) | (8,765) | (6,084) | |||||
Adjusted net income | $ 9,547 | $ 10,182 | $ 23,251 | $ 29,398 | |||||
Adjusted net income margin | 7.2% | 7.9% | 6.2% | 7.5% | |||||
Weighted average shares outstanding - diluted | 43,619,252 | 43,324,995 | 43,539,372 | 43,274,177 | |||||
Adjusted net income per share | $ 0.22 | $ 0.24 | $ 0.53 | $ 0.68 | |||||
Net income per share -- basic and diluted in accordance with GAAP | |||||||||
$ 0.13 | $ 0.13 | $ 0.17 | $ 0.39 | ||||||
Adjusted Operating Income | |||||||||
Operating income | $ 8,602 | $ 9,657 | $ 14,810 | $ 30,281 | |||||
Restructuring and other related charges | 2,441 | 9,608 | 9,515 | 10,755 | |||||
Asbestos liability and defense costs (income) | 2,202 | (4,303) | 4,179 | (1,176) | |||||
Asbestos coverage litigation expenses | 2,339 | 1,845 | 10,763 | 8,838 | |||||
Adjusted operating income | $ 15,584 | $ 16,807 | $ 39,267 | $ 48,698 | |||||
Adjusted operating income margin | 11.8% | 13.1% | 10.5% | 12.4% | |||||
(1) The preliminary results for the three and nine months ended October 1, 2010 and the preliminary restated results for the three and nine months ended October 2, 2009, included herein, reflect management's best estimate of corrections related to the overstatement of the Company's pension liability as described in the Form 8-K filed with the SEC on October 25, 2010. Selling, general and administrative expenses for the nine months ended October 1, 2010, include an estimated correction related to the first six months of 2010, resulting in a reduction of $0.5 million compared to the historical results reported in the Company's Quarterly Report on Form 10-Q for the period ended July 2, 2010. The related net income impact for nine months ended October 1, 2010 is an after-tax benefit of $0.3 million ($.01 per share). Selling, general and administrative expenses for the three and nine months ended October 2, 2009, include estimated corrections resulting in reductions of $0.3 million and $0.8 million, respectively, compared to the historical results reported in the Company's Quarterly Report on Form 10-Q for the period ended October 2, 2009. The related net income impacts for the three and nine months ended October 2, 2009, are after-tax benefits of $0.2 million (less than $.01 per share) and $0.5 million ($.01 per share), respectively. Final results for the current year periods and final restated results for the 2009 periods could change when the analysis of the pension matter is finalized, and these final results will be reflected in the Company's Quarterly Report on Form 10-Q for the period ended October 1, 2010 and amended prior reports, when filed. The Company will amend and restate the consolidated financial statements contained it its Annual Report on Form 10-K for the year ended December 31, 2009 and Quarterly Reports on Form 10-Q for the periods ended April 2, 2010 and July 2, 2010. The Company plans to file the amended reports as soon as practicable in the fourth quarter of 2010. | |||||||||
Colfax Corporation | |||||||||
Change in Sales, Orders and Backlog | |||||||||
Dollars in millions | |||||||||
(Unaudited) | |||||||||
Sales | Orders | ||||||||
Three Months Ended October 2, 2009 | $ 128.5 | $ 117.2 | |||||||
Components of Change: | |||||||||
Existing businesses | 7.6 | 5.9 % | 9.4 | 8.1 % | |||||
Acquisitions | 3.0 | 2.3 % | 3.0 | 2.5 % | |||||
Foreign currency translation | (6.7) | (5.2)% | (5.5) | (4.7)% | |||||
Total | 3.9 | 3.0 % | 6.9 | 5.9 % | |||||
Three Months Ended October 1, 2010 | $ 132.4 | $ 124.1 | |||||||
Backlog at | |||||||||
Sales | Orders | Period End | |||||||
Nine Months Ended October 2, 2009 | $ 394.1 | $ 360.8 | $ 325.3 | ||||||
Components of Change: | |||||||||
Existing businesses | (20.0) | (5.0)% | 36.2 | 10.1 % | (7.2) | (2.2)% | |||
Acquisitions | 4.6 | 1.2 % | 4.7 | 1.3 % | 42.3 | 13.0 % | |||
Foreign currency translation | (3.4) | (0.9)% | (2.5) | (0.7)% | (9.2) | (2.8)% | |||
Total | (18.8) | (4.7)% | 38.4 | 10.7 % | 25.9 | 8.0 % | |||
Nine Months Ended October 1, 2010 | $ 375.3 | $ 399.2 | $ 351.2 | ||||||
Colfax Corporation | ||||
Reconciliation of Projected 2010 Net Income Per Share to Adjusted Net Income Per Share | ||||
Amounts in Dollars | ||||
(Preliminary(1) and unaudited) | ||||
EPS Range | ||||
Projected net income per share - fully diluted | $0.38 | $0.43 | ||
Restructuring and other related charges incurred year-to-date | 0.15 | 0.15 | ||
Estimated restructuring and other related charges (2) | 0.02 | 0.02 | ||
Asbestos coverage litigation expenses | 0.20 | 0.20 | ||
Asbestos liability and defense costs | 0.08 | 0.08 | ||
Projected adjusted net income per share - fully diluted | $0.83 | $0.88 | ||
(1) The preliminary projected net income per share for the year ended December 31, 2010 reflects management's best estimate of corrections related to the overstatement of the Company's pension liability as described in the Form 8-K filed with the SEC on October 25, 2010. Projected 2010 net income per share includes an after-tax benefit of $.01 per share for the estimated correction related to the first six months of 2010, compared to the historical results for that period as reported in the Company's Quarterly Report on Form 10-Q for the period ended July 2, 2010. Final results for the current year periods could change when the analysis of the pension matter is finalized. | ||||
(2) Represents estimated restructuring and other related charges for actions implemented through November 4, 2010. | ||||
SOURCE
News Provided by Acquire Media